% | $
Quotes you view appear here for quick access.

Rockwell Medical, Inc. Message Board

  • a_rajalonghorn a_rajalonghorn Jun 1, 2013 2:28 PM Flag

    RMTI Bull Analysis (part 1)

    Since there seems to be one major voice and he seems to post nothing but a one side argument, here is my analysis.
    So let me start by saying that the views expressed here are my own and I do not advise anyone to buy or sell based upon my analysis. I am long RMTI and in the next few paragraphs i will explain why I believe it to be a good investment in the short term.

    RMTI- Rockwell medical is a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis.

    There are approx 430,000 patients with End Stage Renal Disease (ESRD) being treated with dialysis dialysis in the U.S., and estimated 2.2 million ESRD patients worldwide, who require treatment for anemia. Anemia is a common occurrence in patients with ESRD due to the fact that the kidneys have become damaged and no longer produce and vital hormone called Erythropoietin.

    Currently patients with renal failure are treated with erythropoiesis-stimulating agents (ESA's) for anemia, primarily used in dialysis patients, most of whom have treatments MWF or TTHSAT. ESA's are used in conjunction with IV Iron Dextran to keep the patients hemoglobin levels elevated but can put them at risk for stroke or MI if their hemoglobin goes in the excess of 11g/dl (grams per deciliter). For normal healthy males the level is 14-18 g/dl, females 11-16 g/dl. The current standard of treatment is Erythropoietin (EPO), a synthetic form of the hormone that is produced mainly by the kidneys (before they were damaged). EPO shots are given quite frequently and it can take a month or two before a significant enough rise in hemoglobin/hematocrit levels ( 5%) for the patient to start feeling any better.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
6.23-0.21(-3.26%)Feb 5 4:00 PMEST